CH-001

N/A

Report date: 2023/12/11 18:14:44

NME

Base Information

Drug NameCH-001

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionRNA interferenceOrnithine decarboxylase stimulants

TargetsOrnithine decarboxylase

Therapy Area/IndicationsDiabetes Mellitus

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesFabrus Inc

China Registration ClassN/A

Active CompaniesFabrus Inc

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus

Inactive IndicationsN/A

ATC CodeN/A